Signed Into Law
Signed June 20, 2025Effective 2025-06-20
HB3749

Regular Session

Relating to the regulation of the provision of elective intravenous therapy.

Government Affairs & Regulatory Compliance Analysis

Business Impact

Who HB3749 Affects

Regulatory Priority: critical

Significant regulatory changes (effective 2025-06-20). Review with your legal and compliance teams to understand implications.

Estimated Cost Impact

Need Government Relations Support?

JD Key Consulting provides government affairs and regulatory strategy services. We help businesses navigate Texas agencies, understand legislative impacts, and advocate for their interests.

Need Help Navigating This Legislation?

JD Key Consulting provides strategic guidance on Texas regulatory compliance and legislative impact for your business.

01

Compliance Analysis

Key implementation requirements and action items for compliance with this legislation

Immediate Action Plan

Operational Changes Required

Strategic Ambiguities & Considerations

Need Compliance Guidance on This Legislation?

Schedule a Consultation

Information presented is for general knowledge only and is provided without warranty, express or implied. Consult qualified government affairs professionals and legal counsel before making compliance decisions.

02
03
Quick Reference

Frequently Asked Questions

Common questions about HB3749

Q

What does Texas HB3749 do?

HB3749 fundamentally restructures the elective IV therapy market by imposing strict licensure caps on Medical Directors and narrowing the scope of authorized administrators to RNs, APRNs, and PAs. If your business model relies on "absentee" Medical Directors supervising many locations, or if you utilize LVNs or Paramedics for IV administration, you are non-compliant as of June 20, 2025.

Q

Who authored HB3749?

HB3749 was authored by Texas Representative Angelia Orr during the Regular Session.

Q

When was HB3749 signed into law?

HB3749 was signed into law by Governor Greg Abbott on June 20, 2025.

Q

Which agencies enforce HB3749?

HB3749 is enforced by Texas Board of Nursing and Texas Medical Board.

Q

How significant are the changes in HB3749?

The regulatory priority for HB3749 is rated as "critical". Businesses and organizations should review the legislation to understand potential impacts.

Q

What is the cost impact of HB3749?

The cost impact of HB3749 is estimated as "medium". This may vary based on industry and implementation requirements.

Q

What topics does HB3749 address?

HB3749 addresses topics including occupational regulation, occupational regulation--health occupations, physicians, jenifer's law and nurses & nurse aides.

Q

What are the key dates for HB3749?

Key dates for HB3749: Effective date is 2025-06-20. Consult with legal counsel regarding applicability.

Q

What are the penalties under HB3749?

HB3749 establishes the following penalties: administrative penalty of License revocation, suspension, or administrative penalties (variable) for Physicians delegating the ordering of IV therapy to RNs (must be APRN/PA); Physicians exceeding the statutory cap on Prescriptive Authority Agreements.. Consult with legal counsel for specific applicability to your situation.

Q

Which Texas businesses are affected by HB3749?

HB3749 primarily affects healthcare providers and medical facilities. These businesses should review the legislation with their legal and compliance teams to understand potential impacts.

Legislative data provided by LegiScanLast updated: January 11, 2026